M. Yuri

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

T. Kanno, M. Hiki, Y. Tabe, 2022, Scientific Reports.

Harmonization of quantitative BCR‐ABL measurements using the secondary reference material anchored to the WHO primary standards

S. Kimura, Y. Tabe, S. Morishita, 2015, International journal of laboratory hematology.

A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib

S. Kimura, Y. Tabe, A. Ohsaka, 2018, bioRxiv.

Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux

Y. Tabe, J. Aoki, R. Sadatsuki, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes

Y. Hayashizaki, K. Usui, Y. Tabe, 2018, PloS one.

Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area

Y. Tabe, T. Miida, S. Misawa, 2021, Heliyon.

Comparison of prothrombin time tests used in the monitoring of edoxaban and their evaluation as indicators of the reversal effect

M. Hiki, Y. Tabe, T. Iba, 2016, International Journal of Hematology.

Comparison of the Analytical Performance Between cobas EGFR Assay and PCR-Clamp Method in the Detection of EGFR Mutations in Japanese Non-Small Cell Lung Cancer Patients.

Kenji Suzuki, Kazuhisa Takahashi, Y. Tabe, 2017, Clinical laboratory.